Access to healthcare – where everyone, everywhere can be guaranteed to receive the right medicines or vaccines when they need them ­– is far from a reality.

Yet globally, the healthcare sector is striving to find sustainable ways to deliver on this goal. It means finding innovative ways to provide better access to treatments and vaccines – be it through industry partnerships, more effective data, collaborative ways of working or advancements in insurance design.

Throughout this hub, MSD shines a spotlight on four important areas to better understand what it takes to provide more equitable access to innovative treatments and vaccines.

In this first section, we talk to Rifat Atun, Professor of Global Health Systems at Harvard University, to find out why better cancer care requires better oversight at every stage of the system - and how sustainable investment will be key to transformation.